Hiroomi Tada
2023
In 2023, Hiroomi Tada earned a total compensation of $2.4M as Chief Medical Officer at Tyra Biosciences, a 90% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $305,760 |
---|---|
Option Awards | $1,596,107 |
Salary | $509,600 |
Other | $950 |
Total | $2,412,417 |
Tada received $1.6M in option awards, accounting for 66% of the total pay in 2023.
Tada also received $305.8K in non-equity incentive plan, $509.6K in salary and $950 in other compensation.
Rankings
In 2023, Hiroomi Tada's compensation ranked 411th out of 2,840 executives tracked by ExecPay. In other words, Tada earned more than 85.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 411 | 86th |
Manufacturing | 236 | 85th |
Chemicals And Allied Products | 168 | 81st |
Drugs | 165 | 80th |
Pharmaceutical Preparations | 103 | 83rd |
Tada's colleagues
We found two more compensation records of executives who worked with Hiroomi Tada at Tyra Biosciences in 2023.